home / stock / mscl:cc / mscl:cc articles
No one has written and article on Satellos Bioscience Inc., stock symbol MSCL:CC. Be the first to contribute and write an article.
News, Short Squeeze, Breakout and More Instantly...
Satellos Bioscience Inc. Company Name:
MSCL:CC Stock Symbol:
TSXVC Market:
Satellos Bioscience Inc. Website:
– Investigational New Drug (IND) enabling preclinical and toxicology studies successfully completed – Initiation of a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience Inc. (“Satellos” or the “Company”) ...
–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to initiate a Phase 1 clinical trial in Q3 2024 Satellos Bios...
– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company d...